Rheumatology
Latest articles
22-07-2022 | Rheumatology | News | Article
Leflunomide shows promise in lupus nephritis
Leflunomide, a DMARD used in the treatment of rheumatoid arthritis, is noninferior to azathioprine for the prevention of kidney flares in people with lupus nephritis, Chinese researchers report.
18-07-2022 | Rheumatology | News | Article
LOTUS trial suggests no benefit of ustekinumab in SLE
Development of ustekinumab as a potential therapeutic option for systemic lupus erythematosus has been terminated following an interim analysis of the phase 3 LOTUS trial, which demonstrated no benefit of the IL-12/23 inhibitor in this patient population.